Details for New Drug Application (NDA): 018061
✉ Email this page to a colleague
NDA 018061 describes TIMOLIDE 10-25, which is a drug marketed by Merck and is included in one NDA. Additional details are available on the TIMOLIDE 10-25 profile page.
The generic ingredient in TIMOLIDE 10-25 is hydrochlorothiazide; timolol maleate. There are thirty-two drug master file entries for this compound. Additional details are available on the hydrochlorothiazide; timolol maleate profile page.
The generic ingredient in TIMOLIDE 10-25 is hydrochlorothiazide; timolol maleate. There are thirty-two drug master file entries for this compound. Additional details are available on the hydrochlorothiazide; timolol maleate profile page.
Summary for 018061
| Tradename: | TIMOLIDE 10-25 |
| Applicant: | Merck |
| Ingredient: | hydrochlorothiazide; timolol maleate |
| Patents: | 0 |
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 25MG;10MG | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No | |||||
Expired US Patents for NDA 018061
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Merck | TIMOLIDE 10-25 | hydrochlorothiazide; timolol maleate | TABLET;ORAL | 018061-001 | Approved Prior to Jan 1, 1982 | 3,655,663 | ⤷ Start Trial |
| Merck | TIMOLIDE 10-25 | hydrochlorothiazide; timolol maleate | TABLET;ORAL | 018061-001 | Approved Prior to Jan 1, 1982 | 4,238,485 | ⤷ Start Trial |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Complete Access Available with Subscription
